Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Prostatic Neoplasms 12Urogenital Neoplasms 1Prostatic Diseases 1Neoplasms, Glandular and Epithelial 1Neoplasms 1Metastatic Castration-sensitive Prostate Cancer 1Genital Neoplasms, Male 1Carcinoma 1Adenocarcinoma 1

Interventions

Mitomycin 3Abiraterone Acetate 3motexafin gadolinium 2abiraterone 2Suspensions 2Sunitinib 2Powders 2Paclitaxel 2Gemcitabine 2Drug Therapy 2Docetaxel 2vinflunine 1valrubicin 1temsirolimus 1sipuleucel-T 1pembrolizumab 1palbociclib 1onapristone 1olaparib 1niraparib 1luprolide acetate gel depot 1gallium 68 PSMA-11 1enfortumab vedotin 1darolutamide 1atezolizumab 1apalutamide 1abemaciclib 1Watchful Waiting 1Transurethral Resection of Prostate 1Tinzaparin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
INDUSTRY × Urogenital Neoplasms × luprolide acetate gel depot × Clear all
NCT01431391 2017-05-30

Sequencing of Sipuleucel-T and ADT in Men With Non-metastatic Prostate Cancer

Dendreon

Phase 2 Completed
68 enrolled 11 charts
Genitourinary

Adenocarcinoma, Carcinoma, Genital Neoplasms, Male, Neoplasms, Neoplasms, Glandular and Epithelial, Prostatic Diseases, Prostatic Neoplasms, Urogenital Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡